J7170 Injection., emicizumab-kxwh 0.5 milligrams
J-Codes
Also known as: emicizumab, Hemlibra, bridging antibody
Injection of emicizumab-kxwh, a bispecific monoclonal antibody that bridges Factor Xa and Factor IXa in the coagulation cascade, supplied as 0.5 milligrams per dose.
Clinical Context
Indicated for prophylaxis of breakthrough bleeding in hemophilia A patients with Factor VIII inhibitors (inhibitor patients), administered as prophylactic therapy to prevent bleeding episodes.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.